China Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

China Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

China mammography market was valued at USD 88.26 million in 2021 and is projected to register a CAGR of 11.24% during the forecast period (2022-2027).

The COVID pandemic had an adverse effect on market growth. The national government-mandated response to COVID-19 in China was announced in May 2020. According to the research report "COVID-19: maintaining essential rehabilitation services across the care continuum" published in BMJ Global Health, the country declared a state of emergency and enacted a nationwide lockdown in January 2020. Non-essential services were all put on hold. Some of the measures that were enacted included the prohibition of large public gatherings, worker quarantines, mobility limitations, travel suspensions, and early identification and isolation of patients. Additionally, all non-urgent patients' inpatient rehabilitation was terminated, as were all outpatient therapies. This had an immediate effect on cancer patients. The closure of clinics and diagnostic facilities caused delays in early diagnosis, which affected the final clinical result. Additionally, the National Library of Medicine article "Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China" published in August 2020 focused on standardizing the management procedures for patients with breast cancer who experienced delays and interruptions in their treatment due to the pandemic. One of the study's key findings was the preference for online consultation over face-to-face consultation. As a result, COVID-19 reduced the amount of breast cancer screenings performed in the early stages of the pandemic. In contrast, China took the necessary steps to stop the epidemic and provided smooth access to cancer care services after the lockdown was removed. Thus, the market is expected to grow in the future.

Factors, such as the growing incidences of breast cancer, technological advancements in the field of breast imaging, and the investment from various organizations in breast cancer screening campaigns., are boosting the growth of the market studied. Additionally, according to data from Globocan 2020 published by the International Agency for Research on Cancer, there were 416,000 new instances of breast cancer in China in 2020, with a projected increase to 481,000 cases by 2040. The number of patients seeking mammograms at hospitals across China is anticipated to climb as breast cancer incidence rise. During the projected period, this is anticipated to accelerate market expansion. The increase in awareness of and access to mammography screening services, which are being provided to more women, is another factor contributing to the surge. For instance, the isolated Chinese Qinghai-Tibet plateau will now have access to mammography services, according to an announcement made in July 2021 by Shenzhen Anke High-tech Co. Ltd, a manufacturer of mammography equipment. It was anticipated that this will boost the region's mammography screening rate. Similarly, in October 2020, hospitals all across Shanghai observed breast cancer awareness month by hosting campaigns to increase public knowledge of the condition. The China Primary Health Care Foundation ran the initiative. Thus, it was anticipated that more people would seek out breast scans at hospitals equipped with mammography equipment as a result, fueling market expansion. Thus, the abovementioned factors are expected to increase market growth.

However, the risk of adverse effects from radiation exposure, and reduction in reimbursement are expected to hinder the market growth.

Key Market TrendsSpecialty Clinics Segment is Expected to Hold a Significant Market Share Over the Forecast Period

The high prevalence of breast cancer cases and strategic initiatives by the major clinics are expected to boost the market growth, along with large investments in healthcare expenditure. Additionally, awareness programs are also expected to boost market growth. China has made significant investments in its healthcare system. For instance, the Organization for Economic Co-operation and Development (OECD) estimates that in 2019, the nation spent a total of USD 767.50 billion on healthcare, or 5.35% of its GDP. Numerous clinics have been developed throughout China, notably in the country's major cities, thanks to huge investments. This will probably encourage the development of specialty clinics. Additionally, China had a five-year prevalence of 1,390,095 cases of breast cancer, according to statistics from Globocan 2020 published by the International Agency for Research on Cancer. The number of individuals requesting mammography screenings at clinics across China is anticipated to climb as breast cancer cases rise. During the projected period, this is anticipated to accelerate market expansion. Clinics in China are also carrying out a lot of awareness campaigns. For instance, the Parkway Pantai China group of clinics sought to debunk misconceptions about mammograms and boost awareness of the test in September 2020. During the projected period, initiatives like these are anticipated to enhance market growth since it is possible that more patients would request mammography screenings at clinics. Over the course of the projected period, this is anticipated to accelerate market expansion in this sector.

Therefore, it is anticipated that the aforementioned improvements will further enhance the market growth in this sector.

Competitive Landscape

China mammography market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, Carestream Health Inc., and Koninklijke Philips NV among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.